1-5 of 5
Antonello Sica
Close
Sort by
Journal Articles

Brentuximab Vedotin in the Treatment of Cutaneuous T Cell Lymphomas: A Multicenter, Retrospective, Case-Control Study from Italy

Erika Morsia, Vieri Grandi, Annagiulia Zizzari, Giacomo Loseto, Paolo Fava, Silvia Alberti Violetti, Alessandro Pileri, Alessandro Broccoli, Paola Vitiello, Antonello Sica, Luca Nassi, Cosimo Di Riamondo, Pietro Quaglino, Nicola Pimpinelli, Emilio Berti, Pier Luigi Zinzani, Serena Rupoli
Journal: Blood
Blood (2023) 142 (Supplement 1): 6111.
https://doi.org/10.1182/blood-2023-189116
Published: 2023
Journal Articles

Prospective Evaluation of Minimal Residual Disease in Waldenström Macroglobulinemia across Different Tissues and Treatments: Results of the “BIO-WM” Trial of the Fondazione Italiana Linfomi (FIL)

Martina Ferrante, Daniela Drandi, Silvia Zibellini, Luigi Marcheselli, Chiara Varraso, Veronica Peri, Irene Dogliotti, Davide Musto, Emilia Cappello, Federica Cavallo, Angela Ferrari, Michele Merli, Giulia Zamprogna, Luca Laurenti, Simona Tomasetti, Emanuele Cencini, Giacomo Loseto, Silvia Finotto, Monia Marchetti, Francesca Re, Antonello Sica, Jacopo Olivieri, Giulia Vittoria Facchetti, Cristina Jiménez, Noemi Puig, Giulia Turra, Benedetto Bruno, Ramon Garcia-Sanz, Marzia Varettoni, Simone Ferrero
Journal: Blood
Blood (2023) 142 (Supplement 1): 1621.
https://doi.org/10.1182/blood-2023-181731
Published: 2023
Journal Articles

Characterization of B-Cell and Plasma Cell Compartment By Eight-Color Multiparameter Flow Cytometry in Patients with Waldenstrom Macroglobulinemia Prospectively Enrolled in the Fondazione Italiana Linfomi (FIL) BIO-WM Trial

Marzia Varettoni, Simone Ferrero, MD, Cristina Picone, Milena Gilestro, Noemí Puig, MD PhD, Luigi Marcheselli, Irene Dogliotti, MD, Angela Ferrari, Michele Merli, MD, Giulia Zamprogna, MD, Luca Laurenti, MD, Simona Tomassetti, MD, Emanuele Cencini, MD, Giacomo Loseto, MD, Dario Marino, MDPhD, Monia Marchetti, MD, Francesca Re, MD, Antonello Sica, MD, Jacopo Olivieri, Cristina Jiménez, PhD, Silvia Zibellini, PhD, Daniela Drandi, PhD, Chiara Candido, Martina Ferrante, PhD, Nicole Fabbri, Federica Cavallo, Luca Arcaini, Mario Boccadoro, Ramon Garcia-Sanz
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-137119
Published: 2020
Journal Articles

Second Generation Tyrosine Kinase Inhibitors (2G-TKI) in the Frontline Treatment of Elderly Patients with Chronic Myeloid Leukemia

Fabio Stagno, MD PhD, Roberto Latagliata, Mario Annunziata, MD, Elisabetta Abruzzese, MD, Fausto Castagnetti, MD, Alessandra Iurlo, MD PhD, Monica Bocchia, Monica Crugnola, MD, Nicola Sgherza, Attilio Guarini, MD, Federica Sorà, MD, Isabella Capodanno, Carmen Fava, MD PhD, Antonella Gozzini, MD, Massimiliano Bonifacio, MD, Sabrina Crescenzi Leonetti, MD, Sara Galimberti, PhD MD, Costanzo Feo, MD, Enrico Montefusco, Mario Tiribelli, MD, Patrizia Pregno, MD, Micaela Bergamaschi, MD, Manuela Rizzo, MD, Agostino Antolino, Endri Mauro, MD, Antonella Russo Rossi, MD, Bruno Martino, Raffaele Palmieri, MD, Maria Rosaria Esposito, MD, Maria Iovine, MD, Paolo Danise, Antonello Sica, MD, Paolo Vigneri, MD PhD, Massimo Breccia, MD PhD, Gianantonio Rosti, MD, Robin Foa, MD, Luigiana Luciano
Journal: Blood
Blood (2017) 130 (Supplement 1): 1606.
https://doi.org/10.1182/blood.V130.Suppl_1.1606.1606
Published: 2017
Journal Articles

Efficacy and Safety of Nilotinib in First Line Therapy in a Real Life Cohort of Chronic Myeloid Leukemia Patients

Luigia Luciano, MD, Mario Annunziata, MD, Maria Rosaria Esposito, MD, Palmieri Francesco, MD, Maria Iovine, MD, Paolo Danise, MD, Simona Pagliuca, MD, Giovanna Giagnuolo, MD, Antonello Sica, MD, Roberto Vallone, MD, Marilena Spiezia, MD, Fabrizio Pane, MD
Journal: Blood
Blood (2014) 124 (21): 5531.
https://doi.org/10.1182/blood.V124.21.5531.5531
Published: 2014